Data analysis revealed that glutaminase (GLS) expression was negatively correlated with miR-122 in primary human hepatocellular carcinoma, inhibition of GLS1 reduces oxidative stress and restores VLDL triglyceride output, thereby reducing hepatic steatosis [137], and up-regulation of GLS RNA was associated with advanced tumor grade [138]. This evidence concerns the gene GLS and fatty liver disease.